EWP
UTHR icon

Elevation Wealth Partners’s United Therapeutics UTHR Stock Holding History

Elevation Wealth Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6K Buy
51
+3
+6% +$1.69K 0.01% 481
2026
Q1 		$28.5K Sell
48
-13
-21% -$6.47K 0.01% 316
2025
Q4 		$29.7K Buy
61
+13
+27% +$6.05K 0.01% 308
2025
Q3 		$20.1K Hold
48
– – 0.01% 328
2025
Q2 		$13.8K Hold
48
– – 0.01% 346
2025
Q1 		$14.8K Hold
48
– – 0.01% 338
2024
Q4 		$16.9K Hold
48
– – 0.01% 323
2024
Q3 		$17.2K Hold
48
– – 0.01% 313
2024
Q2 		$15.3K Hold
48
– – 0.01% 311
2024
Q1 		$11K Buy
+48
New +$10.8K 0.01% 345

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Elevation Wealth Partners's UTHR Position: Q2 2026 in Review

Elevation Wealth Partners increased its United Therapeutics (UTHR) stake by 6.3% in Q2 2026, buying an estimated $1.69K and bringing the position to 51 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #481.

Elevation Wealth Partners first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.7K in Q4 2025. 107 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Elevation Wealth Partners held 51 shares of United Therapeutics worth $27.6K as of Q2 2026.
  • Elevation Wealth Partners bought 3 United Therapeutics shares in Q2 2026, an estimated $1.69K.
  • United Therapeutics made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #481 holding.
  • Elevation Wealth Partners first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Elevation Wealth Partners's United Therapeutics position peaked at $29.7K in Q4 2025.
  • 107 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.